---
title: "Total artificial heart system gains entry to US FDA advisory programme"
date: "2025-08-11T11:10:19.000Z"
publishedDate: "11 août 2025"
summary: "Bivacor has announced that its total artificial heart (TAH) system has been accepted into the US Food and Drug Administration’s (FDA) total product life cycle (TPLC) advisory programme—known as the TAP programme. The programme is designed to accelerate the development and patient access to high-impact medical technologies."
importance: ""
sourceUrl: "https://cardiovascularnews.com/total-artificial-heart-system-gains-entry-to-us-fda-advisory-programme/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-08-11-total-artificial-heart-system-gains-entry-to-us-fda-advisory-programme"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/BiVACOR_Total_Artificial_Heart_Surgery-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/total-artificial-heart-system-gains-entry-to-us-fda-advisory-programme/"
---

![Total artificial heart system gains entry to US FDA advisory programme](https://cardiovascularnews.com/wp-content/uploads/sites/14/2024/02/BiVACOR_Total_Artificial_Heart_Surgery-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/total-artificial-heart-system-gains-entry-to-us-fda-advisory-programme/*

## L’essentiel

Bivacor has announced that its total artificial heart (TAH) system has been accepted into the US Food and Drug Administration’s (FDA) total product life cycle (TPLC) advisory programme—known as the TAP programme. The programme is designed to accelerate the development and patient access to high-impact medical technologies.

## Lien source

https://cardiovascularnews.com/total-artificial-heart-system-gains-entry-to-us-fda-advisory-programme/
